Wu et al 1 conducted an interesting study-level meta-analysis comparing the efficacy of PD-1 antibody plus chemotherapy with chemotherapy alone in patients with PD-L1–expressing esophageal squamous ...
Combined GLP 1 receptor agonists and progestin therapy reduces endometrial cancer risk and hysterectomy rates in women with benign uterine conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results